Akebia Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Akebia Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- AKBA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001517022
Board of directors
-
Adrian Adams · DirectorSince 2023
- Since 2023
-
John P. Butler · Director · CEO and PresidentSince 2023
-
Leanne M. Zumwalt · DirectorSince 2023
-
Michael W. Rogers · DirectorSince 2023
-
Myles Wolf · DirectorSince 2023
-
Ron Frieson · DirectorSince 2023
-
Steven C. Gilman · DirectorSince 2023
Chief executives
John P. Butler
· CEO and President
Dates unknown
Board connections
3 of this board's directors also sit on 7 other boards.
- via Cynthia Smith
- via Cynthia Smith
- via Steven C. Gilman
- via Cynthia Smith
- via Adrian Adams
- via Cynthia Smith
- via Steven C. Gilman
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2025 | Leanne M. Zumwalt Director | Grant or award | +35,700 | — | — |
| Jun 10, 2025 | Adrian Adams Director | Grant or award | +35,700 | — | — |
| Jun 10, 2025 | Myles Wolf Director | Grant or award | +35,700 | — | — |
| Jun 10, 2025 | Cynthia Smith Director | Grant or award | +35,700 | — | — |
| Jun 10, 2025 | Michael W. Rogers Director | Grant or award | +35,700 | — | — |
| Jun 10, 2025 | Steven C. Gilman Director | Grant or award | +35,700 | — | — |
| Jun 10, 2025 | Ron Frieson Director | Grant or award | +35,700 | — | — |
| Jun 9, 2025 | Malabre Richard C Officer (SVP, Chief Accounting Officer) | Option exercise | +15,000 | $1.68 | $25,200 |
| Jun 9, 2025 | Malabre Richard C Officer (SVP, Chief Accounting Officer) | Open-market sale | −15,000 | $4.01 | $60,150 |
| Jun 4, 2025 | Malabre Richard C Officer (SVP, Chief Accounting Officer) | Open-market sale | −13,334 | $3.53 | $47,069 |
| Mar 3, 2025 | John P. Butler Director, Officer (CEO and President) | Open-market sale | −46,409 | $1.83 | $84,928 |
| Mar 3, 2025 | Burke Steven Keith Officer (SVP, Chief Medical Officer) | Open-market sale | −7,144 | $1.83 | $13,074 |
| Feb 3, 2025 | John P. Butler Director, Officer (CEO and President) | Open-market sale | −46,268 | $2.10 | $97,163 |
| Feb 3, 2025 | Burke Steven Keith Officer (SVP, Chief Medical Officer) | Open-market sale | −23,270 | $2.10 | $48,867 |
| Feb 3, 2025 | Malabre Richard C Officer (SVP, Chief Accounting Officer) | Open-market sale | −30,202 | $2.10 | $63,424 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.